Literature DB >> 26363100

Anticancer molecule AS1411 exhibits low nanomolar antiviral activity against HIV-1.

Mathieu Métifiot1, Samir Amrane2, Jean-Louis Mergny3, Marie-Line Andreola4.   

Abstract

During clinical trials, a number of fully characterized molecules are dropped along the way because they do not provide enough benefit for the patient. Some of them show limited side effects and might be of great use for other applications. AS1411 is a nucleolin-targeting aptamer that underwent phase II clinical trials as anticancer agent. Here, we show that AS1411 exhibits extremely potent antiviral activity and is therefore an attractive new lead as anti-HIV agent.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Anticancer; Antiviral; G-quadruplexes; Nucleolin; Zintevir

Mesh:

Substances:

Year:  2015        PMID: 26363100     DOI: 10.1016/j.biochi.2015.09.009

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  10 in total

1.  Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.

Authors:  Antonella Messore; Angela Corona; Valentina Noemi Madia; Francesco Saccoliti; Valeria Tudino; Alessandro De Leo; Davide Ialongo; Luigi Scipione; Daniela De Vita; Giorgio Amendola; Ettore Novellino; Sandro Cosconati; Mathieu Métifiot; Marie-Line Andreola; Francesca Esposito; Nicole Grandi; Enzo Tramontano; Roberta Costi; Roberto Di Santo
Journal:  J Med Chem       Date:  2021-06-09       Impact factor: 7.446

2.  G-quadruplex structure of an anti-proliferative DNA sequence.

Authors:  Ngoc Quang Do; Wan Jun Chung; Thi Hong Anh Truong; Brahim Heddi; Anh Tuân Phan
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

3.  G-Quadruplex Identification in the Genome of Protozoan Parasites Points to Naphthalene Diimide Ligands as New Antiparasitic Agents.

Authors:  Efres Belmonte-Reche; Marta Martínez-García; Aurore Guédin; Michela Zuffo; Matilde Arévalo-Ruiz; Filippo Doria; Jenny Campos-Salinas; Marjorie Maynadier; José Juan López-Rubio; Mauro Freccero; Jean-Louis Mergny; José María Pérez-Victoria; Juan Carlos Morales
Journal:  J Med Chem       Date:  2018-01-27       Impact factor: 7.446

4.  Intra-locked G-quadruplex structures formed by irregular DNA G-rich motifs.

Authors:  Arijit Maity; Fernaldo Richtia Winnerdy; Weili Denyse Chang; Gang Chen; Anh Tuân Phan
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

Review 5.  G-quadruplex-based aptamers against protein targets in therapy and diagnostics.

Authors:  Chiara Platella; Claudia Riccardi; Daniela Montesarchio; Giovanni N Roviello; Domenica Musumeci
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-11-16       Impact factor: 3.770

Review 6.  G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives.

Authors:  Carolina Roxo; Weronika Kotkowiak; Anna Pasternak
Journal:  Molecules       Date:  2019-10-21       Impact factor: 4.411

Review 7.  Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.

Authors:  Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-10-09       Impact factor: 6.321

8.  The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell.

Authors:  Rosalba Perrone; Elena Butovskaya; Sara Lago; Alfredo Garzino-Demo; Christophe Pannecouque; Giorgio Palù; Sara N Richter
Journal:  Int J Antimicrob Agents       Date:  2016-03-11       Impact factor: 5.283

9.  The cellular protein nucleolin preferentially binds long-looped G-quadruplex nucleic acids.

Authors:  Sara Lago; Elena Tosoni; Matteo Nadai; Manlio Palumbo; Sara N Richter
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-11-30       Impact factor: 3.770

Review 10.  Progress in cancer drug delivery based on AS1411 oriented nanomaterials.

Authors:  Xin Tong; Lu Ga; Jun Ai; Yong Wang
Journal:  J Nanobiotechnology       Date:  2022-01-31       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.